These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33149331)

  • 1. Opioid-Related Education Provided by Continuing Education Divisions at US Pharmacy Schools.
    Renfro ML; Moczygemba LR; Baumgartner J; Baumgart G; Hill LG
    Am J Pharm Educ; 2020 Oct; 84(10):ajpe8001. PubMed ID: 33149331
    [No Abstract]   [Full Text] [Related]  

  • 2. Development and delivery of a pharmacist training program to increase naloxone access in Kentucky.
    Palmer E; Hart S; Freeman PR
    J Am Pharm Assoc (2003); 2017; 57(2S):S118-S122. PubMed ID: 28161300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing state-mandated training requirements for naloxone-dispensing pharmacists.
    Roberts AW; Carpenter DM; Smith A; Look KA
    Res Social Adm Pharm; 2019 Feb; 15(2):222-225. PubMed ID: 29650444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty Years of ACPE CPE Accreditation.
    Travlos DV; Baumgartner JL; Rouse M; Wadelin JW; Vlasses PH
    Am J Pharm Educ; 2017 Nov; 81(9):5998. PubMed ID: 29302083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory mixed-methods evaluation of continuing education opportunities related to the care of sexual and gender minority patients from ACPE-accredited providers.
    A Nardolillo J; DiLucia A; Kerwin T; Ramirez SR; Vazquez MC; Murry LT; Medlin CG
    Am J Health Syst Pharm; 2024 Apr; 81(8):306-315. PubMed ID: 38150575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Data Submitted by Public and Private Pharmacy Schools to the Opioid-Related Activities Database.
    Khadka S; Peeters MJ
    Am J Pharm Educ; 2021 Jun; 85(6):8328. PubMed ID: 34315703
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuing Professional Development Activities Provided by Continuing Pharmacy Education Providers.
    Murry LT; Whittington B; Travlos DV
    Am J Pharm Educ; 2024 Apr; 88(4):100685. PubMed ID: 38490562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indian Health Service pharmacists engaged in opioid safety initiatives and expanding access to naloxone.
    Duvivier H; Gustafson S; Greutman M; Jangchup T; Harden AK; Reinhard A; Warshany K
    J Am Pharm Assoc (2003); 2017; 57(2S):S135-S140. PubMed ID: 28292501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy on-site overdose protocols and prevention of overdose.
    Green TC; Soipe A; Baloy B; Burstein D; Xuan Z; Tapper A; Walley AY; Case P; Bratberg J; Baird J
    Subst Abus; 2022; 43(1):64-68. PubMed ID: 32186478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy-based statewide naloxone distribution: A novel "top-down, bottom-up" approach.
    Morton KJ; Harrand B; Floyd CC; Schaefer C; Acosta J; Logan BC; Clark K
    J Am Pharm Assoc (2003); 2017; 57(2S):S99-S106.e5. PubMed ID: 28292508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of data.
    Murnane KS; Augustine JM; Marshall LL
    Curr Pharm Teach Learn; 2022 Oct; 14(10):1222-1228. PubMed ID: 36283793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining simulated academic detailing with naloxone training to prepare student pharmacists for opioid risk mitigation strategies.
    Kavanaugh R; Yerks M; Feldman R; Stanton M
    Curr Pharm Teach Learn; 2021 Dec; 13(12):1679-1682. PubMed ID: 34895678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing pharmacists' readiness to dispense naloxone and counsel on responding to opioid overdoses.
    Melaragni F; Levy C; Pedrazzi J; Andersen M
    J Am Pharm Assoc (2003); 2019; 59(4):550-554.e2. PubMed ID: 31109812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model for continuing pharmacy education.
    McConnell KJ; Newlon C; Dickerhofe J
    Am J Pharm Educ; 2009 Aug; 73(5):87. PubMed ID: 19777102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.
    Slocum S; Ozga JE; Joyce R; Walley AY; Pollini RA
    BMC Public Health; 2022 Apr; 22(1):735. PubMed ID: 35418048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of Pharmacy Student Interns into a Naloxone Telephone Outreach Service.
    Rothbauer K; Genisot A; Frey T; JohnsonPharmacy William S Middleton Memorial Veterans Hospital D
    J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):208-215. PubMed ID: 35997489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of mandatory alerts on long-acting opioid prescriptions and the use of a community pharmacy naloxone protocol.
    Coffman R; Johnson A; Frede S; Pleiman M; Johnson K
    J Am Pharm Assoc (2003); 2022; 62(4S):S35-S40.e1. PubMed ID: 34930681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.